US government economists estimate that pharmaceutical deals to reduce some prescription drug prices could save over USD 500bln over a 10yr period, AP reports

The estimate of significant savings from pharmaceutical deals aimed at reducing prescription drug prices highlights the potential for major healthcare policy shifts in the US. This development could positively impact budget forecasts and may influence discussions on broader economic reforms, thereby affecting overall market sentiment and potentially leading to fluctuations in healthcare and pharmaceutical stocks.